NDC properties for "adalimumab-fkjp 40 MG per 0.8 ML Auto-Injector" (RxCUI 2640404)
About this data
The tables show NDC propoerties for adalimumab-fkjp 40 MG per 0.8 ML Auto-Injector with the RxCUI 2640404
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for adalimumab-fkjp 40 MG per 0.8 ML Auto-Injector (RxCUI 2640404)
| BLA | BLA761154 |
|---|---|
| MMSL_CODE | MTH_RXN_BD39564 |
| RxCUI | 2640404 |
| SPL_SET_ID | 053236ef-db39-25a0-e063-6294a90a16a0 |
| SPL_SET_ID | 5cde907d-6747-0e62-db25-1718ee717fe7 |
| SPL_SET_ID | e94548f8-6a95-4159-9db8-6e734febbea0 |
| VUID | 4043251 |
| VUID | 4043253 |
| Prescribable Synonym | adalimumab-fkjp 40 MG in 0.8 ML Auto-Injector |
| RXNAV_STR | 0.8 ML adalimumab-fkjp 50 MG/ML Auto-Injector |
| RxNorm Name | 0.8 ML adalimumab-fkjp 50 MG/ML Auto-Injector |
| RxNorm Synonym | adalimumab-fkjp 40 MG per 0.8 ML Auto-Injector |
| Related queries | Interactions (for RxCUI 2640404) |
NDC Properties
NDC Item 49502041602
| NDC 9 | 49502-416 |
|---|---|
| NDC 10 | 49502-416-02 |
| NDC Item | 49502041602 |
| Packaging | 2 TRAY in 1 KIT (49502-416-02) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT (49502-480-06) / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT (49502-481-06) / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 860490 |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time high | 2025-11-30 |
| Marketing effective time low | 2023-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-416 |
NDC Item 49502041606
| NDC 9 | 49502-416 |
|---|---|
| NDC 10 | 49502-416-06 |
| NDC Item | 49502041606 |
| BLA | BLA761154 |
| FDA SPL set id | 860490 |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time high | 2025-11-30 |
| Marketing effective time low | 2023-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-416 |
NDC Item 51407083402
| NDC 9 | 51407-834 |
|---|---|
| NDC 10 | 51407-834-02 |
| NDC Item | 51407083402 |
| Packaging | 2 TRAY in 1 KIT (51407-834-02) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT (51407-844-02) / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT (51407-845-02) / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 847534 |
| Labeler | Golden State Medical Supply Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-07-06 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 51407-834 |
NDC Item 51407084402
| NDC 9 | 51407-844 |
|---|---|
| NDC 10 | 51407-844-02 |
| NDC Item | 51407084402 |
| Packaging | 1 in 1 TRAY |
| Packaging | 2 in 1 KIT |
| FDA SPL set id | 847534 |
| Labeler | Golden State Medical Supply Inc. |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 51407-844 |
NDC Item 83257002232
| NDC 9 | 83257-022 |
|---|---|
| NDC 10 | 83257-022-32 |
| NDC Item | 83257002232 |
| Packaging | 2 TRAY in 1 KIT (83257-022-32) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 788036 |
| Labeler | Biocon Biologics Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-04-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83257-022 |
NDC Item 49502041602
| NDC 9 | 49502-416 |
|---|---|
| NDC 10 | 49502-416-02 |
| NDC Item | 49502041602 |
| Packaging | 2 TRAY in 1 KIT (49502-416-02) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT (49502-480-06) / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT (49502-481-06) / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 860490 |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time high | 2025-11-30 |
| Marketing effective time low | 2023-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-416 |
NDC Item 49502041606
| NDC 9 | 49502-416 |
|---|---|
| NDC 10 | 49502-416-06 |
| NDC Item | 49502041606 |
| BLA | BLA761154 |
| FDA SPL set id | 860490 |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time high | 2025-11-30 |
| Marketing effective time low | 2023-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-416 |
NDC Item 51407083402
| NDC 9 | 51407-834 |
|---|---|
| NDC 10 | 51407-834-02 |
| NDC Item | 51407083402 |
| Packaging | 2 TRAY in 1 KIT (51407-834-02) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT (51407-844-02) / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT (51407-845-02) / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 847534 |
| Labeler | Golden State Medical Supply Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-07-06 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 51407-834 |
NDC Item 51407084402
| NDC 9 | 51407-844 |
|---|---|
| NDC 10 | 51407-844-02 |
| NDC Item | 51407084402 |
| Packaging | 1 in 1 TRAY |
| Packaging | 2 in 1 KIT |
| FDA SPL set id | 847534 |
| Labeler | Golden State Medical Supply Inc. |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 51407-844 |
NDC Item 83257002232
| NDC 9 | 83257-022 |
|---|---|
| NDC 10 | 83257-022-32 |
| NDC Item | 83257002232 |
| Packaging | 2 TRAY in 1 KIT (83257-022-32) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 788036 |
| Labeler | Biocon Biologics Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-04-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83257-022 |
NDC Item 49502041602
| NDC 9 | 49502-416 |
|---|---|
| NDC 10 | 49502-416-02 |
| NDC Item | 49502041602 |
| Packaging | 2 TRAY in 1 KIT (49502-416-02) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT (49502-480-06) / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT (49502-481-06) / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 860490 |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time high | 2025-11-30 |
| Marketing effective time low | 2023-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-416 |
NDC Item 49502041606
| NDC 9 | 49502-416 |
|---|---|
| NDC 10 | 49502-416-06 |
| NDC Item | 49502041606 |
| BLA | BLA761154 |
| FDA SPL set id | 860490 |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time high | 2025-11-30 |
| Marketing effective time low | 2023-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-416 |
NDC Item 51407083402
| NDC 9 | 51407-834 |
|---|---|
| NDC 10 | 51407-834-02 |
| NDC Item | 51407083402 |
| Packaging | 2 TRAY in 1 KIT (51407-834-02) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT (51407-844-02) / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT (51407-845-02) / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 847534 |
| Labeler | Golden State Medical Supply Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-07-06 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 51407-834 |
NDC Item 51407084402
| NDC 9 | 51407-844 |
|---|---|
| NDC 10 | 51407-844-02 |
| NDC Item | 51407084402 |
| Packaging | 1 in 1 TRAY |
| Packaging | 2 in 1 KIT |
| FDA SPL set id | 847534 |
| Labeler | Golden State Medical Supply Inc. |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 51407-844 |
NDC Item 83257002232
| NDC 9 | 83257-022 |
|---|---|
| NDC 10 | 83257-022-32 |
| NDC Item | 83257002232 |
| Packaging | 2 TRAY in 1 KIT (83257-022-32) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 788036 |
| Labeler | Biocon Biologics Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-04-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83257-022 |
NDC Item 49502041602
| NDC 9 | 49502-416 |
|---|---|
| NDC 10 | 49502-416-02 |
| NDC Item | 49502041602 |
| Packaging | 2 TRAY in 1 KIT (49502-416-02) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT (49502-480-06) / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT (49502-481-06) / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 860490 |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time high | 2025-11-30 |
| Marketing effective time low | 2023-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-416 |
NDC Item 49502041606
| NDC 9 | 49502-416 |
|---|---|
| NDC 10 | 49502-416-06 |
| NDC Item | 49502041606 |
| BLA | BLA761154 |
| FDA SPL set id | 860490 |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time high | 2025-11-30 |
| Marketing effective time low | 2023-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-416 |
NDC Item 51407083402
| NDC 9 | 51407-834 |
|---|---|
| NDC 10 | 51407-834-02 |
| NDC Item | 51407083402 |
| Packaging | 2 TRAY in 1 KIT (51407-834-02) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT (51407-844-02) / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT (51407-845-02) / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 847534 |
| Labeler | Golden State Medical Supply Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-07-06 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 51407-834 |
NDC Item 51407084402
| NDC 9 | 51407-844 |
|---|---|
| NDC 10 | 51407-844-02 |
| NDC Item | 51407084402 |
| Packaging | 1 in 1 TRAY |
| Packaging | 2 in 1 KIT |
| FDA SPL set id | 847534 |
| Labeler | Golden State Medical Supply Inc. |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 51407-844 |
NDC Item 83257002232
| NDC 9 | 83257-022 |
|---|---|
| NDC 10 | 83257-022-32 |
| NDC Item | 83257002232 |
| Packaging | 2 TRAY in 1 KIT (83257-022-32) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 788036 |
| Labeler | Biocon Biologics Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-04-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83257-022 |
NDC Item 49502041602
| NDC 9 | 49502-416 |
|---|---|
| NDC 10 | 49502-416-02 |
| NDC Item | 49502041602 |
| Packaging | 2 TRAY in 1 KIT (49502-416-02) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT (49502-480-06) / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT (49502-481-06) / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 860490 |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time high | 2025-11-30 |
| Marketing effective time low | 2023-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-416 |
NDC Item 49502041606
| NDC 9 | 49502-416 |
|---|---|
| NDC 10 | 49502-416-06 |
| NDC Item | 49502041606 |
| BLA | BLA761154 |
| FDA SPL set id | 860490 |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time high | 2025-11-30 |
| Marketing effective time low | 2023-07-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 49502-416 |
NDC Item 51407083402
| NDC 9 | 51407-834 |
|---|---|
| NDC 10 | 51407-834-02 |
| NDC Item | 51407083402 |
| Packaging | 2 TRAY in 1 KIT (51407-834-02) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT (51407-844-02) / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT (51407-845-02) / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 847534 |
| Labeler | Golden State Medical Supply Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-07-06 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 51407-834 |
NDC Item 51407084402
| NDC 9 | 51407-844 |
|---|---|
| NDC 10 | 51407-844-02 |
| NDC Item | 51407084402 |
| Packaging | 1 in 1 TRAY |
| Packaging | 2 in 1 KIT |
| FDA SPL set id | 847534 |
| Labeler | Golden State Medical Supply Inc. |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 51407-844 |
NDC Item 83257002232
| NDC 9 | 83257-022 |
|---|---|
| NDC 10 | 83257-022-32 |
| NDC Item | 83257002232 |
| Packaging | 2 TRAY in 1 KIT (83257-022-32) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 788036 |
| Labeler | Biocon Biologics Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-04-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83257-022 |